Feb 28 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG EUZG.DE :
* EXTENDS GA-68 ACTIVITIES IN JAPAN
* EXPANDS ITS ACTIVITIES ON GALLIUM-68 (GA-68) LABELED
DIAGNOSTICS
IN JAPAN TOGETHER WITH NOVARTIS PHARMA K.K. (JAPAN)
* FOR THIS PURPOSE, A CLINICAL TRIAL WAS NOTIFIED WITH
JAPANESE
PHARMACEUTICALS AND MEDICAL DEVICES AGENCY (PMDA), STATING
ECKERT & ZIEGLER'S PROPRIETARY GE-68/GA-68 GENERATOR
GALLIAPHARM^® AS SINGLE SOURCE FOR GA-68.
* COLLABORATION WILL GENERATE CONSIDERABLE SALES POTENTIAL
FOLLOWING SUCCESSFUL MARKET APPROVAL.
Source text for Eikon: ID:nEQ7gLGTSa
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))